State Of Wyoming Harmony Biosciences Holdings, Inc. Transaction History

State Of Wyoming

$754 Million
Q4 2024

A detailed history of State Of Wyoming transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, State Of Wyoming holds 6,503 shares of HRMY stock, worth $240,415. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,503

Holding current value

$240,415

% of portfolio

0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $207,185 - $269,809	6,503 New	6,503 $223,000
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $57,504 - $65,887	-1,996 Reduced 39.19%	3,097 $93,000
Q1 2024 May 13, 2024	BUY	$29.93 - $35.06 $43,039 - $50,416	1,438 Added 39.34%	5,093 $171,000
Q4 2023 Feb 14, 2024	BUY	$19.2 - $33.78 $4,339 - $7,634	226 Added 6.59%	3,655 $118,000
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $32,878 - $40,239	1,031 Added 42.99%	3,429 $112,000
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $19,764 - $24,235	648 Added 37.03%	2,398 $84,000
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $8,870 - $15,528	288 Added 19.7%	1,750 $57,000
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $31,734 - $42,576	699 Added 91.61%	1,462 $80,000
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $31,629 - $41,698	752 Added 6836.36%	763 $34,000
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $100 - $156	3 Added 37.5%	11 $1,000
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $33 - $51	1 Added 14.29%	8 $0
Q3 2021 Feb 11, 2022	SELL	$25.68 - $38.61 $102 - $154	-4 Reduced 36.36%	7 $0
Q2 2021 Feb 11, 2022	BUY	$25.96 - $33.44 $103 - $133	4 Added 57.14%	11 $0
Q1 2021 Feb 08, 2022	BUY	$27.56 - $40.37 $192 - $282	7 New	7 $0

Others Institutions Holding HRMY

# of Institutions

254

Shares Held

46.6M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.19B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account